General Information


DRAVP ID  DRAVPe02320

Peptide Name   pep42

Sequence  CTVALPGGYVRVC

Sequence Length  13

UniProt ID  No entry found

Taxon ID  None

Source  Designed In-silico [Pep42 cyclic peptide (CTVALPGGYVRVC) model was built using I-TASSER web server]

Validation   In-Silico



Origin Information


Gene Name/ID  Not Available

GenBank  Not Available

Amino Acid position  Not Available

Domain Accession ID  Not Available

Nucleotide sequence ID  Not Available

Molecular Type  Not Available

Chromosomal Position  Not Available



Activity Information


Target Organism  EBOV

Assay  N/A

Activity  Not Available

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity  No cytotoxicity information found in the reference(s) presented

Binding Target  Cell-surface HSPA5

Mechanism  Pep42 works against the Ebola virus by selectively targeting cell-surface HSPA5, also known as GRP78, which interacts with viral glycoproteins GP1 and GP2. By disrupting the interaction between HSPA5 and viral glycoproteins, Pep42 potentially inhibits viral entry into host cells, thereby reducing viral infection



Structure Information


PDB ID  None

Predicted Structure Download 

Linear/Cyclic  Linear

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C58H96N16O16S2

Absent amino acids  DEFHIKMNOQSUW

Common amino acids  V

Mass  1337.62

Pl  8.06

Basic residues  1

Acidic residues  0

Hydrophobic residues  5

Net charge  1

Boman Index  -0.43

Hydrophobicity  1.1

Aliphatic Index  104.62

Half Life 

  •     Mammalian:1.2hours
  •     Yeast:>20hours
  •     E.coli:>10hours

Extinction Coefficient cystines  1615

Absorbance 280nm  1.207

Polar residues  5



Literature Information


Literature 1

Title   Ebola virus glycoprotein GP1-host cell-surface HSPA5 binding site prediction.

Pubmed ID   32291698

Reference   Cell Stress Chaperones. 2020;25(3):541-548

Author   Elfiky AA, Elfiky AA

DOI   10.1007/s12192-020-01106-z